These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1488405)

  • 1. The bioinequivalence of carbamazepine tablets with a history of clinical failures.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Pelsor FR; Shah VP
    Pharm Res; 1992 Dec; 9(12):1612-6. PubMed ID: 1488405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets.
    Meyer MC; Straughn AB; Mhatre RM; Shah VP; Williams RL; Lesko LJ
    Pharm Res; 1998 Nov; 15(11):1787-91. PubMed ID: 9834004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
    Lake OA; Olling M; Barends DM
    Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food and tablet age on relative bioavailability and pharmacodynamics of two tolbutamide products.
    Olson SC; Ayres JW; Antal EJ; Albert KS
    J Pharm Sci; 1985 Jul; 74(7):735-40. PubMed ID: 4032245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR; Chodos DJ; Phillips JP; DeSante KA; Stoll RG
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):220-7. PubMed ID: 950266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution profile comparison and IVIVR. Carbamazepine case.
    Sathe P; Tsong Y; Shah VP
    Adv Exp Med Biol; 1997; 423():31-42. PubMed ID: 9269481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative bioavailability of four Carbamazepine tablet formulations available in the Kenyan market.
    Oluka MO; Mitema ES; Kibwage IO; Kwasa TO; Kokwaro GO
    East Afr Med J; 1996 May; 73(5):323-6. PubMed ID: 8756037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of acetazolamide tablets.
    Yakatan GJ; Frome EL; Leonard RG; Shah AC; Doluisio JT
    J Pharm Sci; 1978 Feb; 67(2):252-6. PubMed ID: 579636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results.
    Ruiz ME; Conforti P; Fagiolino P; Volonté MG
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):476-85. PubMed ID: 20878879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of carbamazepine 200 mg tablets.
    Kibwage IO; Nguyo M
    East Afr Med J; 1993 Aug; 70(8):512-4. PubMed ID: 8261973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients.
    Silpakit O; Amornpichetkoon M; Kaojarern S
    Ann Pharmacother; 1997 May; 31(5):548-52. PubMed ID: 9161646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carbamazepine: the bioavailability of 4 oral pharmaceutical products].
    Saavedra I; Passalacqua A; Chávez H; Biagini L; Galdames D
    Rev Med Chil; 1990 Oct; 118(10):1123-8. PubMed ID: 2152631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects.
    Marier JF; Manthos H; Kebir S; Ferron S; DiMarco M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Monif T
    Int J Clin Pharmacol Ther; 2006 May; 44(5):240-6. PubMed ID: 16724579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic tolbutamide tablet dissolution: intralot and interlot variation.
    Ayres JW; Huang HP; Albert K
    J Pharm Sci; 1984 Nov; 73(11):1629-34. PubMed ID: 6520768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy.
    Hartley R; Aleksandrowicz J; Bowmer CJ; Cawood A; Forsythe WI
    J Pharm Pharmacol; 1991 Feb; 43(2):117-9. PubMed ID: 1672895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of absorption rate and bioavailability of two brands of carbamazepine.
    Revankar SN; Desai ND; Bhatt AD; Bolar HV; Sane SP; Gupta C; Kamat DV
    J Assoc Physicians India; 1999 Jul; 47(7):699-702. PubMed ID: 10778590
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Abou-Taleb BA; Megallaa MH; Khalafallah NM; Khalil SH
    Drug Dev Ind Pharm; 2020 Feb; 46(2):192-199. PubMed ID: 31937146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of acetazolamide tablets.
    Straughn AB; Gollamudi R; Meyer MC
    Biopharm Drug Dispos; 1982; 3(1):75-82. PubMed ID: 7082781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and central side effects of different carbamazepine tablets.
    Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):226-32. PubMed ID: 3997307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.